CATALYST PHARMACEUTICALS, INC. (CPRX) › Net IncomeCATALYST PHARMACEUTICALS, INC. (CPRX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2002: -$255.9K2003: -$428.6K2004: -$539.8K2005: -$1.81M2006: -$2.73M2007: -$4.14M2008: -$10.56M2009: -$7.24M2010: -$4.01M2011: -$6.39M2012: -$4.08M2013: -$12.15M2014: -$15.51M2015: -$20.23M2016: -$18.07M2017: -$18.41M2018: -$34.00M2019: $31.88M2020: $74.98M2021: $39.48M2022: $83.08M2023: $71.41M2024: $163.89M2025: $214.33M$214.33M2002Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$214.33M+30.8%2024$163.89M+129.5%2023$71.41M-14.0%2022$83.08M+110.4%2021$39.48M-47.3%2020$74.98M+135.2%2019$31.88M+193.7%2018-$34.00M-84.7%2017-$18.41M-1.9%2016-$18.07M+10.7%2015-$20.23M-30.5%2014-$15.51M-27.6%2013-$12.15M-198.2%2012-$4.08M+36.2%2011-$6.39M-59.5%2010-$4.01M+44.7%2009-$7.24M+31.5%2008-$10.56M-155.2%2007-$4.14M-51.7%2006-$2.73M-51.2%2005-$1.81M-234.4%2004-$539.8K-25.9%2003-$428.6K-67.5%2002-$255.9K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share